499 assets in Hepatocellular Carcinoma

Therapeutic assets addressing Hepatocellular Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Candonilimab Hepatocellular Carcinoma	Shi Ming	P2	CC (45)
Casdozokitug Hepatocellular Carcinoma	Coherus Oncology, Inc.	P2	CC (45)
Domvanalimab Hepatocellular Carcinoma	University of Texas Southwestern Medical Center	P2	CC (45)
Dpx-Survivac Hepatocellular Carcinoma	ImmunoVaccine Technologies, Inc. (IMV Inc.)	P2	CC (45)
Eb-G3B7-Nk Dual-Target Car-Nk Cells Hepatocellular Carcinoma	Beijing Biotech	P1/2	CC (45)
Enfortumab Vedotin (Fully Human Monoclonal Antibody Conjugated To A Cytotoxic Agent Monomethyl Auristatin E (Mmae) Targeting Nectin-4) Hepatocellular Carcinoma	H. Lee Moffitt Cancer Center and Research Institute	P2	CC (45)
exl01 Hepatocellular Carcinoma	Center Eugene Marquis	P2	CC (45)
Ezurpimtrostat Hepatocellular Carcinoma	University Hospital, Grenoble	P2	CC (45)
Fluoromisonidazole Hepatocellular Carcinoma	Emory University	P2	CC (45)
Fog-001 Hepatocellular Carcinoma	Parabilis Medicines, Inc.	P1/2	CC (45)
Foslinanib Hepatocellular Carcinoma	TaiRx, Inc.	P2	CC (45)
Fruquintinib Hepatocellular Carcinoma	Sun Yat-sen University	P2	CC (45)
Gdkm-100 Hepatocellular Carcinoma	Guangdong GD Kongming Biotech LLC	P1/2	CC (45)
Gecacitinib Hepatocellular Carcinoma	Tianjin Medical University Cancer Institute and Hospital	P2	CC (45)
Gnos-Pv02 Hepatocellular Carcinoma	Geneos Therapeutics	P1/2	CC (45)
Gns 561 Hepatocellular Carcinoma	Genoscience Pharma	P1/2	CC (45)
gpc3-cart cells Hepatocellular Carcinoma	Chinese PLA General Hospital	P1/2	CC (45)
Immunoglobulin G4 [221-Proline], Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Sg001 ?4-Chain), Disulfide With Human Monoclonal Sg001 ?-Chain, Dimer Hepatocellular Carcinoma	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	P1/2	CC (45)
Individualized Anti-Tumor New Antigen Ineo-Vac-R01 Hepatocellular Carcinoma	Zhejiang University	P1/2	CC (45)
Ineo-Vac-P01 Hepatocellular Carcinoma	Zhejiang University	P1/2	CC (45)
Ineo-Vac-T01 Personalized T Cell Hepatocellular Carcinoma	Zhejiang University	P1/2	CC (45)
Interleukin 18 (Recombinant Human Mutein Clone St-067) Hepatocellular Carcinoma	Simcha IL-18, Inc.	P1/2	CC (45)
js007 Hepatocellular Carcinoma	Shanghai Junshi Bioscience Co., Ltd.	P2	CC (45)
js207 Hepatocellular Carcinoma	Shanghai Junshi Bioscience Co., Ltd.	P2	CC (45)
Lisinopril Hepatocellular Carcinoma	Northwestern University	P2	CC (45)
Memantine Hydrochloride Hepatocellular Carcinoma	Inova Health Care Services	P2	CC (45)
Nogapendekin Alfa Inbakicept Hepatocellular Carcinoma	National Cancer Institute (NCI)	P2	CC (45)
Pd-L1 T-Hank Hepatocellular Carcinoma	ImmunityBio, Inc.	P2	CC (45)
pm1009 Hepatocellular Carcinoma	Biotheus Inc.	P1/2	CC (45)
Ptx-9908 Hepatocellular Carcinoma	TCM Biotech International Corp.	P1/2	CC (45)
Pucotenlimab Hepatocellular Carcinoma	Sun Yat-sen University	P2	CC (45)
Rosiglitazone Hepatocellular Carcinoma	Dan Zandberg	P2	CC (45)
rp2 Hepatocellular Carcinoma	Replimune, Inc.	P2	CC (45)
Simvastatin Hepatocellular Carcinoma	National Cancer Institute (NCI)	P2	CC (45)
Star0602 Hepatocellular Carcinoma	Marengo Therapeutics, Inc.	P1/2	CC (45)
Super Hi-Tcr-T Cells Hepatocellular Carcinoma	Eastern Hepatobiliary Surgery Hospital	P1/2	CC (45)
Surufatinib Hepatocellular Carcinoma	Zhongnan Hospital	P2	CC (45)
Tegavivint Hepatocellular Carcinoma	Iterion Therapeutics	P1/2	CC (45)
Tipiracil Hepatocellular Carcinoma	Parabilis Medicines, Inc.	P1/2	CC (45)
Trifluridine Hepatocellular Carcinoma	Parabilis Medicines, Inc.	P1/2	CC (45)
Ucpvax Hepatocellular Carcinoma	Centre Hospitalier Universitaire de Besancon	P2	CC (45)
Ulixertinib Hepatocellular Carcinoma	National Cancer Institute (NCI)	P2	CC (45)
vg161 Hepatocellular Carcinoma	Virogin Biotech Canada Ltd	P2	CC (45)
Vipivotide Tetraxetan Hepatocellular Carcinoma	Melissa Lumish	P2	CC (45)
Volrustomig Hepatocellular Carcinoma	AstraZeneca	P2	CC (45)
xnw5004 Hepatocellular Carcinoma	Evopoint Biosciences Inc.	P1/2	CC (45)
Zimberelimab Hepatocellular Carcinoma	University of Texas Southwestern Medical Center	P2	CC (45)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer Hepatocellular Carcinoma	National Cancer Institute (NCI)	P2	CC (44)
Nelitolimod Hepatocellular Carcinoma	University of California, San Diego	P1/2	CC (44)
Abbv-324 Hepatocellular Carcinoma	AbbVie	P1	CC (43)

Showing 251 to 300 of 499 assets

PreviousPage 6 of 10Next